呼吸器内科
スタッフの紹介
| 院長 | |
| 医長 | |
| 医長(副内視鏡センター長) | |
| 医師 | |
| 医師 | |
| 医師 | |
| 医師 | |
| レジデント | |
| レジデント | |
| レジデント | |
| 専攻医 | |
| 専攻医 | |
| 専攻医 |
呼吸器内科の概要
当科では、肺がんをはじめとする胸部悪性疾患、細菌性肺炎などの呼吸器感染症、気管支喘息などのアレルギー疾患、間質性肺炎など、幅広い呼吸器疾患の診療を行っています。
県内外より多くの患者さんを紹介いただいており、呼吸器系専門病棟(10階B病棟は呼吸器内科・呼吸器外科、48床)を中心に、常時40～50人、年間1000人を超える入院患者さんの診療にあたっています。特に、硬性気管支鏡を含めた呼吸器インターベンションに積極的に取り組んでおり、他院では対応が難しい症例も受け入れています。
診療は、呼吸器専門医/指導医(日本呼吸器学会)、気管支鏡専門医/指導医(日本呼吸器内視鏡学会)、がん治療認定医(日本がん治療認定医機構)、がん薬物療法専門医/指導医(日本臨床腫瘍学会)、喘息専門医(日本喘息学会)の資格を有する常勤医師と、呼吸器内科レジデント・専攻医が担当しています。
外来は常勤医師が交替で休みなく毎日行っており、1日に30～50名の患者さんに対応しています。24時間オンコール体制を組んでおり、専門性の高い診療と迅速な対応により、地域医療機関と連携しながら、質の高い呼吸器医療の提供に努めています。
認定施設
日本呼吸器学会 認定施設
日本呼吸器内視鏡学会 認定施設
日本がん治療医認定機構 認定研修施設
日本臨床腫瘍学会 認定研修施設
日本肺癌学会 肺癌教育認定施設
日本呼吸器内視鏡学会 認定施設
日本がん治療医認定機構 認定研修施設
日本臨床腫瘍学会 認定研修施設
日本肺癌学会 肺癌教育認定施設
主な診療内容
● 胸部異常陰影に対する精査： 気管支鏡検査(クライオバイオプシーを含む)、CTガイド下生検
● 肺癌に対する治療： 化学療法、放射線療法、分子標的・免疫療法、緩和治療
● 気道狭窄などに対する呼吸器インターベンション(中四国では数施設のみ)
● 感染性肺炎に対する治療： 起炎病原体の推定、適切な抗菌剤の選択
● 間質性肺疾患に対する検査、治療： クライオバイオプシー、抗線維化剤、ステロイドパルス療法、免疫抑制剤を用いた治療など
● 慢性閉塞性肺疾患(COPD)、肺気腫： 気管支拡張剤吸入療法、経気管支肺容量減量術(BLVR)
● 気胸に対する気管支充填材EWS留置
● 慢性呼吸不全： 在宅酸素療法(HOT)の導入、呼吸リハビリテーション、人工呼吸管理
● 気管支喘息に対する治療： ステロイド吸入、気管支拡張剤吸入療法、生物学的製剤
● その他、呼吸器希少疾患など
● 肺癌に対する治療： 化学療法、放射線療法、分子標的・免疫療法、緩和治療
● 気道狭窄などに対する呼吸器インターベンション(中四国では数施設のみ)
● 感染性肺炎に対する治療： 起炎病原体の推定、適切な抗菌剤の選択
● 間質性肺疾患に対する検査、治療： クライオバイオプシー、抗線維化剤、ステロイドパルス療法、免疫抑制剤を用いた治療など
● 慢性閉塞性肺疾患(COPD)、肺気腫： 気管支拡張剤吸入療法、経気管支肺容量減量術(BLVR)
● 気胸に対する気管支充填材EWS留置
● 慢性呼吸不全： 在宅酸素療法(HOT)の導入、呼吸リハビリテーション、人工呼吸管理
● 気管支喘息に対する治療： ステロイド吸入、気管支拡張剤吸入療法、生物学的製剤
● その他、呼吸器希少疾患など
診療実績
当科での呼吸器診療の特徴
1) 気管支鏡検査
2) ガイドラインに準じた肺がんの治療
3) 呼吸器インターベンション
4) 重症喘息に対する生物学的製剤による治療
5) 経気管支肺容量減量術(BLVR：Bronchoscopic Lung Volume Reduction)
6) 間質性肺炎
当科では、年間400件を超える気管支鏡検査を行っています。
ガイドシース法、超音波気管支鏡ガイド下針生検(EBUS-TBNA、EUS-B-FNA)、超音波気管支鏡ガイド下鉗子生検(EBUS-IFB)などの先進的な検査技術を導入しています。さらに、仮想気管支内視鏡(ナビゲーションシステム)や迅速細胞診(ROSE)を組み合わせることで、より正確な診断に努めています。
また、2021年度からはクライオバイオプシーを導入しています。これは、冷却したクライオプローブで組織を凍結しながら採取する方法で、肺がんや間質性肺炎の診断に必要な十分な組織を採取できる検査です。また、気管支内にたまった痰や血液の塊、異物の除去や、悪性腫瘍による気道の狭窄に対する治療にも活用しています。
2) ガイドラインに準じた肺がんの治療
当科では、日本肺癌学会「肺癌診療ガイドライン」に基づき、一人ひとりの患者さんに適した肺がん治療を提供しています。
従来の抗がん剤治療に加え、遺伝子検査や病理検査の結果に基づく分子標的薬や免疫チェックポイント阻害薬など、最新の治療法を積極的に取り入れています。毎年更新される肺癌診療ガイドラインや新しい治療法にも迅速に対応し、科学的根拠に基づいた最適な治療を提供できるよう努めています。
また、治療が難しい段階においても、患者さん一人ひとりの状態や希望を大切にし、より良い治療とケアを提供できるよう診療を行っています。
詳しくは、「NHO岡山医療センターの肺がん診療」をご覧ください。
3) 呼吸器インターベンション
当科では、全身麻酔下で硬性気管支鏡を用いた高度な気道内視鏡治療を行っています。気道狭窄に対するシリコンステント(狭くなった気道を広げるための医療用チューブ)留置などの専門的な治療に対応しており、中国・四国地方でも実施施設は限られています。
また、軟性気管支鏡を用いたさまざまな内視鏡治療にも積極的に取り組み、県内外から紹介される緊急性の高い患者さんにも迅速に対応しています。
4) 重症喘息に対する生物学的製剤による治療
喘息治療では、ステロイドと長時間作動型β₂刺激薬(ICS/LABA)の吸入療法を基本としています。それでも症状のコントロールが難しい重症喘息の患者さんには、生物学的製剤(オマリズマブ、メポリズマブ、ベンラリズマブ、デュピルマブ、テゼペルマブなど)を用いた治療を行っています。患者さんの症状や検査結果、喘息のタイプを総合的に評価し、一人ひとりに適した治療を選択することで、症状の改善や増悪の予防、生活の質(QOL)の向上を目指しています。
5) 経気管支肺容量減量術(BLVR：Bronchoscopic Lung Volume Reduction)
当院では、2024年9月より重症肺気腫に対する経気管支肺容量減量術(BLVR)を実施しています。
BLVRは、気管支鏡を用いて気管支内に一方向弁(バルブ)を留置し、病変の強い肺を縮小させることで、呼吸機能の改善を目指す内視鏡治療です。2023年12月に国内で承認された新しい治療法で、適応となる患者さんでは息切れの軽減や運動能力・肺機能の改善が期待されます。
当科では、患者さんの病状を十分に評価したうえで、BLVRの適応を慎重に判断し、安全で質の高い治療を提供しています。
6) 間質性肺炎
間質性肺炎は、肺で酸素を取り込む「肺胞」の壁(間質)に炎症や傷が起こり、肺が硬くなる(線維化する)病気です。肺が硬くなると十分な酸素を取り込めなくなり、息切れや咳などの症状が現れます。
間質性肺炎には、原因がわかっているもの(膠原病、薬剤、アレルギーなど)と、原因がはっきりしない「特発性間質性肺炎」があります。病気の種類によって治療法や経過が異なるため、正確な診断が重要です。
治療について、炎症が主体の間質性肺炎では、副腎皮質ステロイド薬や免疫抑制薬が有効なことがあります。肺の線維化が進行するタイプでは、抗線維化薬(ニンテダニブ、ピルフェニドン)により、肺機能の低下を遅らせることが期待できます。また、進行性線維化を示す一部の間質性肺疾患にも抗線維化薬が使用されます。
近年は新しい抗線維化治療の開発が進んでおり、従来薬との併用を含めた新たな治療法の有効性が報告されています。今後さらに治療の選択肢が広がることが期待されています。
過去5年間の業績
英語論文
1. Takigawa Y, Sato K, Kudo K, Goda M, Shiraha K, Matsumoto S, Ichikawa T, Inoue T, Matsuoka S, Fujiwara M, Taoka M, Nishimura J, Watanabe H, Uka M, Minami D, Taniguchi A, Ochi N, Shoda H, Ishikawa N, Nogami S, Fujiwara K, Shibayama T. Bridging therapy with airway stent placement followed by immune checkpoint inhibitors in patients with lung cancer and malignant airway disorders: A retrospective study. Respir Investig. 2026;64(3):101403.
2. Takigawa Y, Sato K, Matsuoka S, Matsuo Y, Goda M, Shiraha K, Watanabe H, Nishimura J, Kudo K, Fujiwara K, Shibayama T. Usefulness of Novel Balloon-Less Convex Probe Bronchoscope for Diagnosing and Staging of Lung Cancer via EBUS-TBNA and EUS-B-FNA. Respirol Case Rep. 2026;14(2):e70506
3. Fujiwara M, Baba T, Yamada K, Nakamura E, Takeguchi T, Takigawa Y, Morita A, Hara N, Watanabe H, Ninomiya K, Rai K, Ichihara E, Ohashi K, Hotta K, Sato K, Maeda Y, Togashi Y, Makimoto G. Endotracheal and Endobronchial Metastases in Epidermal Growth Factor Receptor Exon 19 Deletion Lung Adenocarcinoma: A Case Successfully Managed with Bronchoscopic Therapy and Sequential Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Intern Med. 2026;65(11):1520-1523.
4. Fujiwara M, Takigawa Y, Sato K, Inoue T, Matsuoka S, Watanabe H, Kudo K, Sato A, Fujiwara K, Shibayama T. The Safety and Efficacy of a Transbronchial Lung Cryobiopsy Using a 1.7-mm Cryoprobe in Older Adult Patients with Suspected Interstitial Lung Disease: A Single-center, Retrospective, Observational Study. Intern Med. 2026 Mar 3. doi: 10.2169/internalmedicine.6521-25. Online ahead of print.
5. Ichikawa T, Sato K, Sasano Y, Matsumoto S, Matsuoka S, Takigawa Y, Watanabe H, Kudo K, Sato A, Fujiwara K, Shibayama T. Selpercatinib-induced Acalculous Cholecystitis in an Elderly Patient with RET Fusion-positive Non-small Cell Lung Cancer: A Case Report. Intern Med. 2026;65(13):1799-1804.
6. Ichikawa T, Kudo K, Takigawa Y, Osedo T, Sasano Y, Kitano T, Nishimura J, Watanabe H, Sato K, Fujiwara K. Favorable Response to Chemotherapy with Durvalumab plus Tremelimumab in Two Cases of KRAS G12C-Positive Pulmonary Sarcomatoid Carcinoma: A Case Report. Intern Med. 2026 Mar 17. doi: 10.2169/internalmedicine.6660-25. Online ahead of print.
7. Sakai M, Matsuoka S, Takigawa Y, Kinoshita A, Sasano Y, Matsumoto S, Nishimura J, Watanabe H, Kudo K, Sato K, Fujiwara K, Shibayama T. Early benralizumab use for the successful treatment of eosinophilic granulomatosis with polyangiitis-associated peripheral neuropathy: A case report. Intern Med. 2026 Mar 10. doi: 10.2169/internalmedicine.6825-25. Online ahead of print.
8. Arimori S, Takigawa Y, Sato K, Ichikawa T, Inoue T, Watanabe H, Kudo K, Fujiwara K, Shibayama T. EUS-B-FNA Enabled Pathological Diagnosis After Airway Stenting due to Severe Stenosis by Adenocarcinoma. Respirol Case Rep. 2026;14(1):e70476.
9. Sugihara T, Takigawa Y, Sato K, Ido S, Ichikawa T, Chikama S, Watanabe H, Sando Y, Akagi Y, Kudo K, Sato A, Fujiwara K, Nogami S, Shibayama T. Safe Bronchoscopic Treatment Strategy for Subglottic Severe Airway Stenosis: A Case Report of Tracheal MALT Lymphoma. Respirol Case Rep. 2026;14(2):e70519.
10. Murakami R, Takigawa Y, Sato K, Ichikawa T, Matsumoto S, Inoue T, Matsuoka S, Watanabe H, Kudo K, Sato A, Fujiwara K, Nogami S, Shibayama T. Management of Airway Foreign Bodies Caused by Dental Prostheses Complicated by Obstructive Pneumonia: A Report of Two Cases. Respirol Case Rep. 2026;14(2):e70517.
11. Kogure Y, Hashimoto H, Ikeda S, Harada T, Hino A, Miura S, Goto Y, Fujiwara K, Katakami N, Kubota K, Murata N, Mori M, Abe T, Saito AM, Yamamoto N, Saka H, Kondo M. Efficacy of pembrolizumab plus pemetrexed in older patients with non-squamous NSCLC according to PD-L1 expression status: Results from the CJLSG1901 study. Cancer Treat Res Commun. 2026:46:101094.
12. Takigawa Y, Sato K, Matsuoka S, Goda M, Shiraha K, Ichikawa T, Matsumoto S, Inoue T, Fujiwara M, Nishimura J, Watanabe H, Kudo K, Sato A, Isoda T, Shinno Y, Fujiwara K, Shibayama T. Additional 1.1-mm cryobiopsy trial guided by rapid on-site cytologic evaluation of touch imprint cytology result of small forceps biopsy in peripheral pulmonary lesions: a prospective single-center study. Transl Lung Cancer Res. 2025;14(12):5273-5282.
13. Takigawa Y, Sato K, Matsumoto S, Ichikawa T, Inoue T, Matsuoka S, Watanabe H, Kudo K, Sato A, Fujiwara K. Role of bronchoscopic mucus plug removal in the diagnosis and treatment of allergic bronchopulmonary mycosis using the new criteria: A single-centre, retrospective study. Respir Investig. 2025;63(4):495-499.
14. Takigawa Y, Sato K, Miyake K, Matsuoka S, Matsumoto S, Ichikawa T, Nishimura J, Watanabe H, Kudo K, Fujiwara K. Diagnosis of right upper lobe lesion using the SUKEDACHI balloon with thin-bronchoscope to facilitate close-to-lesion transbronchial biopsy: Novel bronchoscopic technique. Respir Investig. 2025;63(5):853-856.
15. Takigawa Y, Sato K, Watanabe H, Ido S, Ichikawa T, Matsumoto S, Matsuoka S, Nishimura J, Kudo K, Fujiwara K, Shibayama T. Customised Dumon Y-Stent With Reversed Orientation for Management of Complex Airway Obstruction in Endobronchial Non-Small-Cell Lung Cancer: Clinical Image of a Successful Airway Salvage. Respirol Case Rep. 2025;13(6):e70240.
16. Takigawa Y, Sato K, Minami D, Kudo K, Matsumoto S, Fujiwara M, Ichikawa T, Inoue T, Matsuoka S, Watanabe H, Sato A, Shoda H, Ishikawa N, Fujiwara K, Shibayama T. Successful stent removal after chemoradiotherapy followed by durvalumab for locally advanced non-small cell lung cancer with airway stenosis: A report of three cases. Respir Med Case Rep. 2025;55:102217.
17. Matsuoka S, Kudo K, Goda M, Inoue T, Kitano T, Sasano Y, Fujiwara K. Case of Life-threating Asthma Exacerbation Successfully Treated with Benralizumab. Intern Med. 2025;64(15):2382-2385.
18. Matsuoka S, Watanabe H, Inoue T, Takigawa Y, Kudo K, Sato A, Sato K, Fujiwara K, Shibayama T. Lorlatinib Induced Non-cardiogenic Pulmonary Edema. Intern Med. 2025;64(21):3126-3129.
19. Matsuoka S, Sato K, Takigawa Y, Senoo S, Inoue T, Fujiwara M, Watanabe H, Kudo K, Sato A, Fujiwara K, Shibayama T. Lepidic Pulmonary Metastasis from Pancreatic Carcinoma Mimicking Organizing Pneumonia, Diagnosed by a Transbronchial Cryobiopsy. Intern Med. 2025;64(8):1211-1215.
20. Matsuoka S, Takigawa Y, Kudo K, Sato K, Nishimura J, Watanabe H, Fujiwara K, Shibayama T. Recurrent Thymoma Diagnosed by Endobronchial Ultrasound-Guided Fine-Needle Aspiration: A Case Report. Respirol Case Rep. 2025;13(10):e70381.
21. Matsuoka S, Takigawa Y, Sato K, Nishimura J, Watanabe H, Kudo K, Fujiwara K, Shibayama T. Subglottic Stenosis After COVID-19 Mimicking Bronchial Asthma, Treated by Bronchoscopic Resection. Respirol Case Rep. 2025;13(10):e70377.
22. Ichikawa T, Takigawa Y, Fujiwara K, Inoue T, Matsumoto S, Shiraha K, Goda M, Matsuoka S, Watanabe H, Kudo K, Sato A, Sato K, Shibayama T. Successful Treatment of Steroid-Dependent Severe Eosinophilic Pneumonia With Benralizumab: A Case Report. Respirol Case Rep. 2025;13(11):e70417.
23. Matsumoto S, Takigawa Y, Sato K, Honda K, Otsuki M, Ido S, Goda M, Shiraha K, Ichikawa T, Matsuoka S, Nishimura J, Watanabe H, Kudo K, Fujiwara K, Shibayama T. Aspirated Soybean Mimicking Endobronchial Tumour Removed With a Cryoprobe. Respirol Case Rep. 2025;13(10):e70366.
24. Shiraha K, Takigawa Y, Sato K, Goda M, Matsuoka S, Watanabe H, Kudo K, Fujiwara K, Shibayama T. Self-Expectoration of Airway Stent Following Chemoimmunotherapy in Extensive Disease Small Cell Lung Cancer. Respirol Case Rep. 2025;13(6):e70225.
25. Kakiuchi M, Takigawa Y, Sato K, Watanabe H, Kudo K, Sato A, Fujiwara K, Shibayama T. Allergic Bronchopulmonary Mycosis Caused by Schizophyllum commune Successfully Treated With Mepolizumab. Respirol Case Rep. 2025;13(3):e70161.
26. Matsuo Y, Takigawa Y, Sato K, Kudo K, Watanabe H, Sato A, Fujiwara K, Shibayama T. A Case of Malignant Airway Obstruction Mimicking Bronchial Asthma. Respirol Case Rep. 2025;13(3):e70169.
27. Urakami T, Goda M, Takigawa Y, Sato K, Ido S, Furutaguchi M, Matsumoto S, Fujiwara K. Successful Placement of a Silicone Y-Stent Using the Pullback Technique Through a Self-Expandable Metallic Stent in a Case of Tuberculous Airway Stenosis. Respirol Case Rep. 2025;13(12):e70428.
28. Ichihara E, Mitsuhashi T, Tsuge M, Hasegawa K, Kudo K, Tanimoto Y, Nouso K, Oda N, Mitsumune S, Kimura G, Yamada H, Takata I, Hagiya H, Taniguchi A, Tsukahara K, Aokage T, Toyooka S, Tsukahara H, Maeda Y. Association Between Initial Symptoms and Clinical Outcomes in COVID-19. Cureus. 2025;17(5):e84919.
29. Ochi N, Ichihara E, Yokoyama T, Inoue K, Tamura T, Watanabe H, Takata I, Kano H, Nakamura K, Kawai H, Inoue M, Fujimoto N, Ichikawa H, Ando C, Oze I, Takigawa N, Maeda Y, Hotta K. Impact of antibiotic use on survival in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor and chemotherapy. Int J Clin Oncol. 2025;30(11):2277-2286.
30. Hotta K, Saeki S, Sakata S, Yamaguchi M, Harada D, Bessho A, Tanaka K, Inoue K, Inoue K, Gemba K, Kubo T, Sato A, Ichihara E, Watanabe H, Kishimoto J, Shioyama Y, Katsui K, Sugio K, Kiura K. Five-year outcomes with gefitinib induction and chemoradiotherapy in EGFR-mutant stage III non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study. Int J Clin Oncol. 2025;30(3):497-503.
31. Juge M, Imada T, Hirose M, Sato K. Anastrozole-induced interstitial lung disease followed by tamoxifen-induced agranulocytosis in a patient with breast cancer. Int Cancer Conf J. 2025;14(2): 91-96.
32. Takigawa Y, Sato K, Kudo K, Inoue T, Fujiwara M, Matsuoka S, Watanabe H, Sato A, Mukai T, Fujiwara K. Safety and efficacy of airway stent placement following bronchial artery embolization: A retrospective study at a single institute. Respir Investig. 2024;62(4):640-644.
33. Takigawa Y, Sato K, Kudo K, Minami D, Shiraha K, Inoue T, Matsuoka S, Fujiwara M, Mitsumune S, Watanabe H, Sato A, Fujiwara K, Shibayama T. Effectiveness of AERO Stent Placement for Malignant Airway Disorder in Patients with a Poor Performance Status. Intern Med. 2024;63(16):2277-2282.
34. Takigawa Y, Sato K, Kudo K, Minami D, Shiraha K, Inoue T, Matsuoka S, Fujiwara M, Mitsumune S, Watanabe H, Sato A, Fujiwara K, Shibayama T. Effectiveness of AERO Stent Placement for Malignant Airway Disorder in Patients with a Poor Performance Status. Intern Med. 2024;63(16):2277-2282.
35. Takigawa Y, Watanabe H, Sato K, Goda M, Inoue T, Fujiwara M, Matsuoka S, Kudo K, Sato A, Fujiwara K, Shibayama T. Successful ultrathin bronchoscopy with cryobiopsy for diagnosing and removing mucus plugs in allergic bronchopulmonary mycosis mimicking lung cancer. Respirol Case Rep. 2024;12(4):e01359.
36. Takigawa Y, Sato K, Inoue T, Takada M, Fujiwara K. Image of a thawed frozen specimen obtained using a cryoprobe floated with oil droplets in normal saline: An endobronchial lipomatous hamartoma image. Respirol Case Rep. 2024;12(3):e01318.
37. Takigawa Y, Sato K, Inoue T, Sato A, Furutaguchi Y, Goda M, Shiraha K, Fujiwara M, Matsuoka S, Mitsumune S, Watanabe H, Kudo K, Fujiwara K, Shibayama T. Airway stenosis secondary to mediastinal lymph node metastasis of lung adenocarcinoma treated with AERO stent and osimertinib: A case report. Respirol Case Rep. 2024;12(5):e01383.
38. Takigawa Y, Sato K, Kudo K, Ichikawa T, Sasano Y, Matsumoto S, Inoue T, Fujiwara M, Matsuoka S, Watanabe H, Sato A, Fujiwara K, Shibayama T. Successful treatment of tracheal stenosis due to a broken uncovered metallic stent placed over 20 years ago in a patient with recurrent polychondritis using argon plasma coagulation and airway ballooning. Respirol Case Rep. 2024;12(9):e70034.
39. Takigawa Y, Sato K, Inoue T, Takada M, Fujiwara K. Image of a thawed frozen specimen obtained using a cryoprobe floated with oil droplets in normal saline: An endobronchial lipomatous hamartoma image. Respirol Case Rep. 2024;12(3):e01318.
40. Takigawa Y, Watanabe H, Sato K, Matsuoka S, Kudo K, Sato A, Isoda T, Shinno Y, Fujiwara K, Shibayama T. A Case of Lung Metastasis of Breast Cancer Diagnosed Using Ultrathin Bronchoscopic Cryobiopsy with a "Tube-wedging Method". Respir Endosc. 2024;2(1):32-35.
41. Takigawa Y, Miyake K, Sato K, Fujiwara K, Shiraha K, Inoue T, Fujiwara M, Matsuoka S, Watanabe H, Kudo K, Sato A, Watanabe Y, Shibayama T. Improved Bronchial Tree Image Reconstruction from the Lateral Decubitus Position of Computed Tomography Images for Virtual Navigation: A Case Report. Respir Endosc. 2024;2(1):48-52.
42. Matsuoka S, Fujiwara K, Takigawa Y, Ito S, Mitsumune S, Shiraha K, Goda M, Inoue T, Fujiwara M, Nakamura E, Watanabe H, Kudo K, Sato A, Sato K, Shibayama T. Secondary Pulmonary Alveolar Proteinosis Development during the Treatment for Anti-aminoacyl-tRNA Synthetase Antibody-positive Interstitial Lung Disease. Intern Med. 2024;63(21):2971-2976.
43. Matsuoka S, Takigawa Y, Sato K, Sato A, Isoda T. Follicular Lymphoma Diagnosed Successfully via Endobronchial Ultrasound-Guided Intranodal Forceps Biopsy Located in Left Lymph Node #12. Cureus. 2024;16(11):e73486.
44. Matsuoka S, Takigawa Y, Sato K, Inoue T, Watanabe H, Kudo K, Sato A, Fujiwara K, Shibayama T. Convex endobronchial ultrasound bronchoscope may enhance visualization and diagnosis by respiratory physicians: Clinical image of an endoscopic ultrasound with bronchoscope. Respirol Case Rep. 2024;12(11):e70072.
45. Fujiwara M, Watanabe H, Takigawa Y, Goda M, Shiraha K, Inoue T, Matsuoka S, Kudo K, Sato A, Sato K, Fujiwara K, Shibayama T. Successful treatment of type B2 thymoma with steroid and radiotherapy. Respirol Case Rep. 2024;12(8):e70006
46. Shiraha K, Watanabe H, Fujiwara K, Goda M, Inoue T, Fujiwara M, Matsuoka S, Takigawa Y, Mitsumune S, Kudo K, Sato A, Sato K, Shinno Y, Shibayama T. Autopsy case of meningoencephalitis induced by nivolumab and ipilimumab in a patient being treated for non-small cell lung cancer. Intern Med. 2024;63(24):3345-3351.
47. Shiraha K, Takigawa Y, Sato A, Fujiwara K, Matsuo Y, Goda M, Inoue T, Nakamura E, Fujiwara M, Matsuoka S, Watanabe H, Kudo K, Sato K, Shibayama T. Large-vessel vasculitis induced by pegfilgrastim and immune checkpoint inhibitor in a patient with small-cell lung cancer. Respirol Case Rep. 2024;12(2):e01291.
48. Taoka M, Ichihara E, Yokoyama T, Inoue K, Tamura T, Sato A, Oda N, Kano H, Nakamura K, Kawai H, Inoue M, Ochi N, Fujimoto N, Ichikawa H, Ando C, Oze I, Kiura K, Maeda Y, Hotta K. Frequency and Significance of Body Weight Loss During Immunochemotherapy in Patients with Advanced Non-Small Cell Lung Cancer. Cancers (Basel). 2024;16(23):4089.
49. Ichihara E, Ochi N, Makimoto G, Kudo K, Harada D, Ozaki Y, Nishio H, Tsuchihashi K, Miura Y, Endo M, Yano S, Maruyama D, Yoshinami T, Susumu N, Takekuma M, Motohashi T, Ito M, Baba E, Uchino K, Kimura T, Kamiyama Y, Nakao S, Tamura S, Nishimoto H, Kato Y, Sato A, Takano T, Kubo T. Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022. Int J Clin Oncol. 2024;29(4):355-362.
50. Tsuge M, Ichihara E, Hasegawa K, Kudo K, Tanimoto Y, Nouso K, Oda N, Mitsumune S, Kimura G, Yamada H, Takata I, Mitsuhashi T, Taniguchi A, Tsukahara K, Aokage T, Hagiya H, Toyooka S, Tsukahara H, Maeda Y. Increased Oxidative Stress and Decreased Citrulline in Blood Associated with Severe Novel Coronavirus Pneumonia in Adult Patients. Int J Mol Sci. 2024;25(15):8370.
51. Shiiba R, Sano M, Kogure Y, Murao H, Takigawa Y, Torii A, Yamada A, Shinohara Y, Niwa H, Kitagawa C, Oki M. A case of community-acquired Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus (MRSA) necrotizing pneumonia successfully treated with two anti-MRSA drugs. Respir Med Case Rep. 2024;49:102023.
52. Fujiwara S, Higuchi Y, Furujo M, Goda M, Takigawa Y, Sato K, Hitomi K, Mukai W, Oiwa M. Seven-year-old boy with severe dyspnoea and influenza virus infection. J Paediatr Child Health. 2024;60(10):619-620.
53. Morita A, Ichihara E, Inoue K, Fujiwara K, Yokoyama T, Harada D, Ando C, Kano H, Oda N, Tamura T, Ochi N, Kawai H, Inoue M, Hara N, Fujimoto N, Ichikawa H, Oze I, Hotta K, Maeda Y, Kiura K. Impacts of probiotics on the efficacies of immune checkpoint inhibitors with or without chemotherapy for patients with advanced non-small-cell lung cancer. Int J Cancer. 2024;154(9):1607-1615.
54. Kuribayashi T, Ohashi K, Nishii K, Ninomiya K, Tsubata Y, Ishikawa N, Kodani M, Kanaji N, Yamasaki M, Fujitaka K, Kuyama S, Takigawa N, Fujimoto N, Kubota T, Inoue M, Fujiwara K, Harita S, Takata I, Takada K, Okawa S, Kiura K, Hotta K. Clinical characteristics of patients treated with immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: CS-Lung-003 prospective observational registry study. J Cancer Res Clin Oncol. 2024;150(2):89.
55. Oguma T, Ishiguro T, Kamei K, Tanaka J, Suzuki J, Hebisawa A, Obase Y, Mukae H, Tanosaki T, Furusho S, Kurokawa K, Watai K, Matsuse H, Harada N, Nakamura A, Shibayama T, Baba R, Fukunaga K, Matsumoto H, Ohba H, Sakamoto S, Suzuki S, Tanaka S, Yamada T, Yamasaki A, Fukutomi Y, Shiraishi Y, Toyotome T, Fukunaga K, Shimoda T, Konno S, Taniguchi M, Tomomatsu K, Okada N, Asano K, Japan ABPM Research Program. Clinical characteristics of allergic bronchopulmonary mycosis caused by Schizophyllum commune. Clin Transl Allergy. 2024;14(1):e12327.
56. Miyake K, Senoo S, Shiiba R, Itano J, Kimura G, Kawahara T, Tamura T, Kudo K, Kawamura T, Nakahara Y, Higo H, Himeji D, Takigawa N, Miyahara N, Okayama Resp Dis Study Grp ORDSG. Pneumocystis jirovecii pneumonia mortality risk associated with preceding long-term steroid use for the underlying disease: A multicenter, retrospective cohort study. PLoS One. 2024;19(2): e0292507.
57. Takigawa Y, Fujiwara K, Tabuchi I, Kudo K, Hayashi K, Matsumoto S, Omori H, Matsuoka S, Mitsumune S, Watanabe H, Sato A, Sato K, Shibayama T. Successful Treatment with Mepolizumab for Coronary Spastic Angina Associated with Eosinophilic Granulomatosis with Polyangiitis. Intern Med. 2023;62(16):2389-2393.
58. Takigawa Y, Watanabe H, Omote Y, Kurihara S, Inoue T, Fujiwara M, Mitsumune S, Onishi K, Kudo K, Sato A, Sato K, Fujiwara K, Shibayama T. Lambert-Eaton Myasthenic Syndrome Recurrence Induced by Pembrolizumab in a Patient with Non-small-cell Lung Cancer. Intern Med. 2023;62(7):1055-1058.
59. Goda M, Takigawa Y, Fujiwara K, Shinno Y. Upper Lobe-predominant Autoimmune Pulmonary Alveolar Proteinosis. Intern Med. 2023;62(10):1569-1570.
60. Shiraha K, Takigawa Y, Watanabe H, Fujiwara M, Shibayama T. Bronchoscopic Findings of Hereditary Hemorrhagic Telangiectasia. Respir Endosc. 2023;1(2):137-138.
61. Minami D, Takigawa N, Sato K, Fujiwara K, Shibayama T. Distress during Bronchoscopy in Patients Who Underwent Endobronchial Intubation Using Fentanyl and Midazolam without Throat Anesthesia: A Prospective Study. Respir Endosc. 2023;1(1):1-5.
62. Minami D, Onishi K, Hosoya T, Hosoya M, Fujiwara K. Lung Adenocarcinoma with Massive Calcified Lymphadenopathy and Thyroid Metastases. Respir Endosc. 2023;1(1):26-27.
63. Kubo T, Ichihara E, Harada D, Inoue K, Fujiwara K, Hosokawa S, Kishino D, Kawai H, Ochi N, Oda N, Hara N, Hotta K, Tabata M, Maeda Y, Kiura K. Efficacy of immune checkpoint inhibitor monotherapy in elderly patients with non-small-cell lung cancer. Respir Investig. 2023;61(5):643-650.
64. Ando C, Ichihara E, Nishi T, Morita A, Hara N, Takada K, Nakasuka T, Watanabe H, Kano H, Nishii K, Makimoto G, Kondo T, Ninomiya K, Fujii M, Kubo T, Ohashi K, Matsuoka KI, Hotta K, Tabata M, Maeda Y, Kiura K. Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK-rearranged non-small cell lung cancer. Cancer Sci. 2023;114(11):4343-4354.
65. Ichihara E, Hasegawa K, Kudo K, Tanimoto Y, Nouso K, Oda N, Mitsumune S, Yamada H, Takata I, Hagiya H, Mitsuhashi T, Taniguchi A, Toyooka S, Tsukahara K, Aokage T, Tsukahara H, Kiura K, Maeda Y. A randomized controlled trial of teprenone in terms of preventing worsening of COVID-19 infection. PLoS One. 2023;18(10):e0287501.
66. Ninomiya T, Ishikawa N, Kozuki T, Kuyama S, Inoue K, Yokoyama T, Kanaji N, Yasugi M, Shibayama T, Aoe K, Ochi N, Fujitaka K, Kodani M, Ueda Y, Watanabe K, Bessho A, Sugimoto K, Oze I, Hotta K, Kiura K. A randomized phase II study of afatinib alone or combined with bevacizumab for treating chemo-naïve patients with non-small cell lung cancer harboring EGFR mutations. Lung Cancer. 2023;184:107349.
67. Ichihara E, Ochi N, Makimoto G, Kudo K, Harada D, Ozaki Y, Nishio H, Tsuchihashi K, Miura Y, Endo M, Yano S, Maruyama D, Yoshinami T, Susumu N, Takekuma M, Motohashi T, Ito M, Baba E, Uchino K, Kimura T, Kamiyama Y, Nakao S, Tamura S, Nishimoto H, Kato Y, Sato A, Takano T, Kubo T. Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022. Int J Clin Oncol. 2023;29(4):355-362.
68. Ando C, Ichihara E, Yokoyama T, Inoue K, Tamura T, Fujiwara K, Oda N, Kano H, Kishino D, Watanabe K, Inoue M, Ochi N, Onishi F, Ichikawa H, Kobe H, Tachibana S, Hotta K, Maeda Y, Kiura K. More than one-third of advanced non-small-cell lung cancer patients do not receive immunochemotherapy due to intolerance. J Cancer Res Clin Oncol. 2023;149(8):4933-4938.
69. Nakasuka T, Ohashi K, Nishii K, Hirabae A, Okawa S, Tomonobu N, Takada K, Ando C, Watanabe H, Makimoto G, Ninomiya K, Fujii M, Kubo T, Ichihara E, Hotta K, Tabata M, Kumon H, Maeda Y, Kiura K. PD-1 blockade augments CD8+ T cell dependent antitumor immunity triggered by Ad-SGE-REIC in Egfr-mutant lung cancer. Lung Cancer. 2023;178:1-10.
70. Kogure Y, Kada A, Hashimoto H, Atagi S, Takiguchi Y, Saka H, Ebi N, Inoue A, Kurata T, Fujita Y, Nishii Y, Itani H, Endo T, Saito AM, Shibayama T, Yamamoto N, Gemma A. Survival Impact of Second-Line Immune Checkpoint Inhibitors in Older Patients With Advanced Squamous-Cell NSCLC: Post Hoc Analysis of the CAPITAL Study. JTO Clin Res Rep. 2023;4(6):100514.
71. Takigawa Y, Sato K, Inoue A, Nagae M, Inoue T, Onishi K, Mitsumune S, Watanabe H, Kudo K, Sato A, Fujiwara K, Shibayama T. Acute eosinophilic pneumonia caused by nicotine-free vaping in an adolescent patient: A case report. Respirol Case Rep. 2022;10(6):e0961.
72. Tanzawa S, Makiguchi T, Tasaka S, Inaba M, Ochiai R, Nakamura J, Inoue K, Kishikawa T, Nakashima M, Fujiwara K, Kohyama T, Ishida H, Kuyama S, Miyazawa N, Nakamura T, Miyawaki H, Oda N, Ishikawa N, Morinaga R, Kusaka K, Miyamoto Y, Yokoyama T, Matsumoto C, Tsuda T, Ushijima S, Shibata K, Shibayama T, Bessho A, Kaira K, Misumi T, Shiraishi K, Matsutani N, Seki N. Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study). Ther Adv Med Oncol. 2022;14:17588359221116603.
73. Nishimura T, Ichihara E, Yokoyama T, Inoue K, Tamura T, Sato K, Oda N, Kano H, Kishino D, Kawai H, Inoue M, Ochi N, Fujimoto N, Ichikawa H, Ando C, Hotta K, Maeda Y, Kiura K. The Effect of Pleural Effusion on Prognosis in Patients with Non-Small Cell Lung Cancer Undergoing Immunochemotherapy: A Retrospective Observational Study. Cancers (Basel). 2022;14(24):6184.
74. Nishii K, Ohashi K, Tomida S, Nakasuka T, Hirabae A, Okawa S, Nishimura J, Higo H, Watanabe H, Kano H, Ando C, Makimoto G, Ninomiya K, Kato Y, Kubo T, Ichihara E, Hotta K, Tabata M, Toyooka S, Udono H, Maeda Y, Kiura K. CD8+ T-cell Responses Are Boosted by Dual PD-1/VEGFR2 Blockade after EGFR Inhibition in Egfr-Mutant Lung Cancer. Cancer Immunol Res. 2022;10(9):1111-1126.
75. Noumi T, Watanabe H, Ninomiya K, Ohashi K, Ichihara E, Kubo T, Makimoto G, Kato Y, Fujii M, Tabata M, Maeda Y, Hotta K, Kiura K. COVID-19 Vaccine-Associated Lymphadenopathy Mimicking Regrowth of Axillary Lymph Node Metastasis of Lung Adenocarcinoma. Acta Med Okayama. 2022;76(5):593-596.
76. Terai H, Soejima K, Shimokawa A, Horinouchi H, Shimizu J, Hase T, Kanemaru R, Watanabe K, Ninomiya K, Aragane N, Yanagitani N, Sakata Y, Seike M, Fujimoto D, Kasajima M, Kubo A, Kusumoto S, Oyamada Y, Fujiwara K, Mori M, Hashimoto M, Shingyoji M, Kodani M, Sakamoto J, Agatsuma T, Kashiwabara K, Inomata M, Tachihara M, Tanaka K, Hayashihara K, Koyama N, Matsui K, Minato K, Jingu D, Sakashita H, Hara S, Naito T, Okada A, Tanahashi M, Sato Y, Asano K, Takeda T, Nakazawa K, Harada T, Shibata K, Kato T, Miyaoka E, Yoshino I, Gemma A, Mitsudomi T. Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance Data. JTO Clin Res Rep. 2022;3(11):100404.
77. Tanaka H, Tanzawa S, Misumi T, Makiguchi T, Inaba M, Honda T, Nakamura J, Inoue K, Kishikawa T, Nakashima M, Fujiwara K, Kohyama T, Ishida H, Kuyama S, Miyazawa N, Nakamura T, Miyawaki H, Oda N, Ishikawa N, Morinaga R, Kusaka K, Fujimoto N, Fukuda Y, Yasugi M, Tsuda T, Ushijima S, Shibata K, Shibayama T, Bessho A, Kaira K, Shiraishi K, Matsutani N, Seki N. A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis. Ther Adv Med Oncol. 2022;14:17588359221142786.
78. Matsuura H, Fujiwara K, Omori H, Onishi K, Kuribayashi T, Mitsumune S, Takigawa Y, Kudo K, Minami D, Sato A, Sato K, Shibayama T. Successful Treatment with Benralizumab for Allergic Bronchopulmonary Aspergillosis that Developed after Disastrous Heavy Rainfall in Western Japan. Intern Med. 2021;60(9):1443-1450.
79. Matsuura H, Fujiwara K, Omori H, Onishi K, Kuribayashi T, Mitsumune S, Takigawa Y, Kudo K, Sato A, Sato K, Shibayama T. Reply to "Benralizumab as First-line Treatment for ABPA: Is It Really Indicated?". Intern Med. 2021;60(15):2521.
80. Takada K, Fujiwara K, Ando E, Onishi K, Kuribayashi T, Mitsumune S, Takigawa Y, Matsuura H, Watanabe H, Kudo K, Sato A, Sato K, Shibayama T. Optic Perineuritis Associated with Nivolumab Treatment for Non-Small Cell Lung Cancer. Case Rep Oncol. 2021;14(2):792-796.
81. Kuribayashi T, Fujiwara K, Onishi K, Mitsumune S, Takigawa Y, Watanabe H, Kudo K, Sato A, Sato K, Kitagawa M, Ota K, Shinno Y, Shibayama T. Thrombotic Microangiopathy Associated with Gemcitabine in Non-Small Cell Lung Cancer: A Case Report. Case Rep Oncol. 2021;14(3):1712-1718.
82. Minami D, Murakami E, Shibata Y, Nakamura K, Kishino T, Takigawa N, Onishi K, Takigawa Y, Shimonishi A, Kudo K, Sato A, Sato K, Fujiwara K, Shibayama T. End-tidal capnographic monitoring during flexible bronchoscopy under fentanyl and midazolam sedation. Ann Palliat Med. 2021;10(8):8665-8671.
83. Ninomiya K, Yokoyama T, Hotta K, Oze I, Katsui K, Hata T, Yoshioka H, Bessho A, Hosokawa S, Kuyama S, Kudo K, Kozuki T, Harada D, Yasugi M, Murakami T, Nakanishi M, Takigawa N, Maeda Y, Kiura K; Okayama Lung Cancer Study Group. A randomized trial of sodium alginate prevention of esophagitis in LA-NSCLC receiving chemoradiotherapy: OLCSG1401. Support Care Cancer. 2021;29(9):5237-5244.
84. Ninomiya T, Nogami N, Kozuki T, Harada D, Kubo T, Ohashi K, Ichihara E, Kuyama S, Kudo K, Bessho A, Sakugawa M, Fujimoto N, Aoe K, Minami D, Sugimoto K, Ochi N, Takigawa N, Hotta K, Maeda Y, Kiura K.. Survival of chemo-naïve patients with EGFR mutation-positive advanced non-small cell lung cancer after treatment with afatinib and bevacizumab: updates from the Okayama Lung Cancer Study Group Trial 1404. Jpn J Clin Oncol. 2021;51(8):1269-1276.
85. Tamura T, Ninomiya K, Kubo T, Kuyama S, Tachibana S, Inoue K, Chikamori K, Kudo K, Ochi N, Harada D, Maeda Y, Kiura K. Short-term safety of an anti-severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine for patients with advanced lung cancer treated with anticancer drugs: A multicenter, prospective, observational study. Thorac Cancer. 2021;13(3):453-459.
86. Watanabe H, Ichihara E, Kayatani H, Makimoto G, Ninomiya K, Nishii K, Higo H, Ando C, Okawa S, Nakasuka T, Kano H, Hara N, Hirabae A, Kato Y, Ninomiya T, Kubo T, Rai K, Ohashi K, Hotta K, Tabata M, Maeda Y, Kiura K. VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene-driven non-small-cell lung cancers. Cancer Sci. 2021;112(5):1853-1864.
87. Nishii K, Ohashi K, Watanabe H, Makimoto G, Nakasuka T, Higo H, Ninomiya K, Kato Y, Kubo T, Rai K, Ichihara E, Hotta K, Tabata M, Maeda Y, Kiura K. Triple therapy with osimertinib, bevacizumab and cetuximab in EGFR-mutant lung cancer with HIF-1α/TGF-α expression. Oncol Lett. 2021;22(3):639.
88. Kano H, Ichihara E, Watanabe H, Nishii K, Ando C, Nakasuka T, Ninomiya K, Kato Y, Kubo T, Rai K, Ohashi K, Hotta K, Tabata M, Maeda Y, Kiura K. SHP2 Inhibition Enhances the Effects of Tyrosine Kinase Inhibitors in Preclinical Models of Treatment-naïve ALK-, ROS1-, or EGFR-altered Non-small Cell Lung Cancer. Mol Cancer Ther. 2021;20(9):1653-1662.
89. Nakasuka T, Ohashi K, Watanabe H, Kubo T, Matsumoto S, Goto K, Hotta K, Maeda Y, Kiura K. A case of dramatic reduction in cancer-associated thrombus following initiation of pembrolizumab in patient with a poor performance status and PD-L1 + lung adenocarcinoma harboring CCDC6-RET fusion gene and NF1/TP53 mutations. Lung Cancer. 2021;156:1-4.
90. Hara N, Ichihara E, Harada D, Inoue K, Fujiwara K, Hosokawa S, Kishino D, Kawai H, Ochi N, Oda N, Hotta K, Maeda Y, Kiura K. Significance of PD-L1 expression in the cytological samples of non-small cell lung cancer patients treated with immune checkpoint inhibitors. J Cancer Res Clin Oncol. 2021;147(12):3749-3755.
91. Nishii K, Inoue M, Obata H, Ueda Y, Kozuki T, Yamasaki M, Moritaka T, Awaya Y, Sugimoto K, Gemba K, Kuyama S, Ichikawa H, Shibayama T, Kubota T, Kodani M, Kishino D, Fujimoto N, Ishikawa N, Tsubata Y, Ishii T, Fujitaka K, Hotta K, Kiura K. Novel prospective umbrella-type lung cancer registry study for clarifying clinical practice patterns: CS-Lung-003 study protocol. Thorac Cancer. 2021;12(5):725-731.
92. Ochi N, Ichihara E, Takigawa N, Harada D, Inoue K, Shibayama T, Hosokawa S, Kishino D, Harita S, Oda N, Hara N, Hotta K, Maeda Y, Kiura K. The effects of antibiotics on the efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancer differ based on PD-L1 expression. Eur J Cancer. 2021;149:73-81.
93. Ochi N, Ichihara E, Takigawa N, Harada D, Inoue K, Shibayama T, Hosokawa S, Kishino D, Harita S, Oda N, Hara N, Hotta K, Maeda Y, Kiura K. Response to letter re: The effects of antibiotics on the efficacy of immune-checkpoint inhibitors in non-small cell lung cancer patients differ according to PD-L1 expression. Eur J Cancer. 2021;157:523-524.
94. Ichihara E, Harada D, Inoue K, Shibayama T, Hosokawa S, Kishino D, Harita S, Ochi N, Oda N, Hara N, Hotta K, Maeda Y, Kiura K. Characteristics of patients with EGFR-mutant non-small-cell lung cancer who benefited from immune checkpoint inhibitors. Cancer Immunol Immunother. 2021;70(1):101-106.
95. Hosokawa S, Ichihara E, Bessho A, Harada D, Inoue K, Shibayama T, Kishino D, Harita S, Ochi N, Oda N, Hara N, Hotta K, Maeda Y, Kiura K. Impact of previous thoracsic radiation therapy on the efficacy of immune checkpoint inhibitors in advanced non-smasll-cell lung cancer. Jpn J Clin Oncol. 2021;51(2):279-286.
96. Tanzawa S, Ushijima S, Shibata K, Shibayama T, Bessho A, Kaira K, Misumi T, Shiraishi K, Matsutani N, Tanaka H, Inaba M, Haruyama T, Nakamura J, Kishikawa T, Nakashima M, Iwasa K, Fujiwara K, Kohyama T, Kuyama S, Miyazawa N, Nakamura T, Miyawaki H, Ishida H, Oda N, Ishikawa N, Morinaga R, Kusaka K, Fujimoto N, Yokoyama T, Gemba K, Tsuda T, Nakagawa H, Ono H, Shimizu T, Nakamura M, Kusumoto S, Hayashi R, Shirasaki H, Ochi N, Aoe K, Kanaji N, Kashiwabara K, Inoue H, Seki N. A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study). Ther Adv Med Oncol. 2021;13:1758835921998588.
2. Takigawa Y, Sato K, Matsuoka S, Matsuo Y, Goda M, Shiraha K, Watanabe H, Nishimura J, Kudo K, Fujiwara K, Shibayama T. Usefulness of Novel Balloon-Less Convex Probe Bronchoscope for Diagnosing and Staging of Lung Cancer via EBUS-TBNA and EUS-B-FNA. Respirol Case Rep. 2026;14(2):e70506
3. Fujiwara M, Baba T, Yamada K, Nakamura E, Takeguchi T, Takigawa Y, Morita A, Hara N, Watanabe H, Ninomiya K, Rai K, Ichihara E, Ohashi K, Hotta K, Sato K, Maeda Y, Togashi Y, Makimoto G. Endotracheal and Endobronchial Metastases in Epidermal Growth Factor Receptor Exon 19 Deletion Lung Adenocarcinoma: A Case Successfully Managed with Bronchoscopic Therapy and Sequential Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Intern Med. 2026;65(11):1520-1523.
4. Fujiwara M, Takigawa Y, Sato K, Inoue T, Matsuoka S, Watanabe H, Kudo K, Sato A, Fujiwara K, Shibayama T. The Safety and Efficacy of a Transbronchial Lung Cryobiopsy Using a 1.7-mm Cryoprobe in Older Adult Patients with Suspected Interstitial Lung Disease: A Single-center, Retrospective, Observational Study. Intern Med. 2026 Mar 3. doi: 10.2169/internalmedicine.6521-25. Online ahead of print.
5. Ichikawa T, Sato K, Sasano Y, Matsumoto S, Matsuoka S, Takigawa Y, Watanabe H, Kudo K, Sato A, Fujiwara K, Shibayama T. Selpercatinib-induced Acalculous Cholecystitis in an Elderly Patient with RET Fusion-positive Non-small Cell Lung Cancer: A Case Report. Intern Med. 2026;65(13):1799-1804.
6. Ichikawa T, Kudo K, Takigawa Y, Osedo T, Sasano Y, Kitano T, Nishimura J, Watanabe H, Sato K, Fujiwara K. Favorable Response to Chemotherapy with Durvalumab plus Tremelimumab in Two Cases of KRAS G12C-Positive Pulmonary Sarcomatoid Carcinoma: A Case Report. Intern Med. 2026 Mar 17. doi: 10.2169/internalmedicine.6660-25. Online ahead of print.
7. Sakai M, Matsuoka S, Takigawa Y, Kinoshita A, Sasano Y, Matsumoto S, Nishimura J, Watanabe H, Kudo K, Sato K, Fujiwara K, Shibayama T. Early benralizumab use for the successful treatment of eosinophilic granulomatosis with polyangiitis-associated peripheral neuropathy: A case report. Intern Med. 2026 Mar 10. doi: 10.2169/internalmedicine.6825-25. Online ahead of print.
8. Arimori S, Takigawa Y, Sato K, Ichikawa T, Inoue T, Watanabe H, Kudo K, Fujiwara K, Shibayama T. EUS-B-FNA Enabled Pathological Diagnosis After Airway Stenting due to Severe Stenosis by Adenocarcinoma. Respirol Case Rep. 2026;14(1):e70476.
9. Sugihara T, Takigawa Y, Sato K, Ido S, Ichikawa T, Chikama S, Watanabe H, Sando Y, Akagi Y, Kudo K, Sato A, Fujiwara K, Nogami S, Shibayama T. Safe Bronchoscopic Treatment Strategy for Subglottic Severe Airway Stenosis: A Case Report of Tracheal MALT Lymphoma. Respirol Case Rep. 2026;14(2):e70519.
10. Murakami R, Takigawa Y, Sato K, Ichikawa T, Matsumoto S, Inoue T, Matsuoka S, Watanabe H, Kudo K, Sato A, Fujiwara K, Nogami S, Shibayama T. Management of Airway Foreign Bodies Caused by Dental Prostheses Complicated by Obstructive Pneumonia: A Report of Two Cases. Respirol Case Rep. 2026;14(2):e70517.
11. Kogure Y, Hashimoto H, Ikeda S, Harada T, Hino A, Miura S, Goto Y, Fujiwara K, Katakami N, Kubota K, Murata N, Mori M, Abe T, Saito AM, Yamamoto N, Saka H, Kondo M. Efficacy of pembrolizumab plus pemetrexed in older patients with non-squamous NSCLC according to PD-L1 expression status: Results from the CJLSG1901 study. Cancer Treat Res Commun. 2026:46:101094.
12. Takigawa Y, Sato K, Matsuoka S, Goda M, Shiraha K, Ichikawa T, Matsumoto S, Inoue T, Fujiwara M, Nishimura J, Watanabe H, Kudo K, Sato A, Isoda T, Shinno Y, Fujiwara K, Shibayama T. Additional 1.1-mm cryobiopsy trial guided by rapid on-site cytologic evaluation of touch imprint cytology result of small forceps biopsy in peripheral pulmonary lesions: a prospective single-center study. Transl Lung Cancer Res. 2025;14(12):5273-5282.
13. Takigawa Y, Sato K, Matsumoto S, Ichikawa T, Inoue T, Matsuoka S, Watanabe H, Kudo K, Sato A, Fujiwara K. Role of bronchoscopic mucus plug removal in the diagnosis and treatment of allergic bronchopulmonary mycosis using the new criteria: A single-centre, retrospective study. Respir Investig. 2025;63(4):495-499.
14. Takigawa Y, Sato K, Miyake K, Matsuoka S, Matsumoto S, Ichikawa T, Nishimura J, Watanabe H, Kudo K, Fujiwara K. Diagnosis of right upper lobe lesion using the SUKEDACHI balloon with thin-bronchoscope to facilitate close-to-lesion transbronchial biopsy: Novel bronchoscopic technique. Respir Investig. 2025;63(5):853-856.
15. Takigawa Y, Sato K, Watanabe H, Ido S, Ichikawa T, Matsumoto S, Matsuoka S, Nishimura J, Kudo K, Fujiwara K, Shibayama T. Customised Dumon Y-Stent With Reversed Orientation for Management of Complex Airway Obstruction in Endobronchial Non-Small-Cell Lung Cancer: Clinical Image of a Successful Airway Salvage. Respirol Case Rep. 2025;13(6):e70240.
16. Takigawa Y, Sato K, Minami D, Kudo K, Matsumoto S, Fujiwara M, Ichikawa T, Inoue T, Matsuoka S, Watanabe H, Sato A, Shoda H, Ishikawa N, Fujiwara K, Shibayama T. Successful stent removal after chemoradiotherapy followed by durvalumab for locally advanced non-small cell lung cancer with airway stenosis: A report of three cases. Respir Med Case Rep. 2025;55:102217.
17. Matsuoka S, Kudo K, Goda M, Inoue T, Kitano T, Sasano Y, Fujiwara K. Case of Life-threating Asthma Exacerbation Successfully Treated with Benralizumab. Intern Med. 2025;64(15):2382-2385.
18. Matsuoka S, Watanabe H, Inoue T, Takigawa Y, Kudo K, Sato A, Sato K, Fujiwara K, Shibayama T. Lorlatinib Induced Non-cardiogenic Pulmonary Edema. Intern Med. 2025;64(21):3126-3129.
19. Matsuoka S, Sato K, Takigawa Y, Senoo S, Inoue T, Fujiwara M, Watanabe H, Kudo K, Sato A, Fujiwara K, Shibayama T. Lepidic Pulmonary Metastasis from Pancreatic Carcinoma Mimicking Organizing Pneumonia, Diagnosed by a Transbronchial Cryobiopsy. Intern Med. 2025;64(8):1211-1215.
20. Matsuoka S, Takigawa Y, Kudo K, Sato K, Nishimura J, Watanabe H, Fujiwara K, Shibayama T. Recurrent Thymoma Diagnosed by Endobronchial Ultrasound-Guided Fine-Needle Aspiration: A Case Report. Respirol Case Rep. 2025;13(10):e70381.
21. Matsuoka S, Takigawa Y, Sato K, Nishimura J, Watanabe H, Kudo K, Fujiwara K, Shibayama T. Subglottic Stenosis After COVID-19 Mimicking Bronchial Asthma, Treated by Bronchoscopic Resection. Respirol Case Rep. 2025;13(10):e70377.
22. Ichikawa T, Takigawa Y, Fujiwara K, Inoue T, Matsumoto S, Shiraha K, Goda M, Matsuoka S, Watanabe H, Kudo K, Sato A, Sato K, Shibayama T. Successful Treatment of Steroid-Dependent Severe Eosinophilic Pneumonia With Benralizumab: A Case Report. Respirol Case Rep. 2025;13(11):e70417.
23. Matsumoto S, Takigawa Y, Sato K, Honda K, Otsuki M, Ido S, Goda M, Shiraha K, Ichikawa T, Matsuoka S, Nishimura J, Watanabe H, Kudo K, Fujiwara K, Shibayama T. Aspirated Soybean Mimicking Endobronchial Tumour Removed With a Cryoprobe. Respirol Case Rep. 2025;13(10):e70366.
24. Shiraha K, Takigawa Y, Sato K, Goda M, Matsuoka S, Watanabe H, Kudo K, Fujiwara K, Shibayama T. Self-Expectoration of Airway Stent Following Chemoimmunotherapy in Extensive Disease Small Cell Lung Cancer. Respirol Case Rep. 2025;13(6):e70225.
25. Kakiuchi M, Takigawa Y, Sato K, Watanabe H, Kudo K, Sato A, Fujiwara K, Shibayama T. Allergic Bronchopulmonary Mycosis Caused by Schizophyllum commune Successfully Treated With Mepolizumab. Respirol Case Rep. 2025;13(3):e70161.
26. Matsuo Y, Takigawa Y, Sato K, Kudo K, Watanabe H, Sato A, Fujiwara K, Shibayama T. A Case of Malignant Airway Obstruction Mimicking Bronchial Asthma. Respirol Case Rep. 2025;13(3):e70169.
27. Urakami T, Goda M, Takigawa Y, Sato K, Ido S, Furutaguchi M, Matsumoto S, Fujiwara K. Successful Placement of a Silicone Y-Stent Using the Pullback Technique Through a Self-Expandable Metallic Stent in a Case of Tuberculous Airway Stenosis. Respirol Case Rep. 2025;13(12):e70428.
28. Ichihara E, Mitsuhashi T, Tsuge M, Hasegawa K, Kudo K, Tanimoto Y, Nouso K, Oda N, Mitsumune S, Kimura G, Yamada H, Takata I, Hagiya H, Taniguchi A, Tsukahara K, Aokage T, Toyooka S, Tsukahara H, Maeda Y. Association Between Initial Symptoms and Clinical Outcomes in COVID-19. Cureus. 2025;17(5):e84919.
29. Ochi N, Ichihara E, Yokoyama T, Inoue K, Tamura T, Watanabe H, Takata I, Kano H, Nakamura K, Kawai H, Inoue M, Fujimoto N, Ichikawa H, Ando C, Oze I, Takigawa N, Maeda Y, Hotta K. Impact of antibiotic use on survival in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor and chemotherapy. Int J Clin Oncol. 2025;30(11):2277-2286.
30. Hotta K, Saeki S, Sakata S, Yamaguchi M, Harada D, Bessho A, Tanaka K, Inoue K, Inoue K, Gemba K, Kubo T, Sato A, Ichihara E, Watanabe H, Kishimoto J, Shioyama Y, Katsui K, Sugio K, Kiura K. Five-year outcomes with gefitinib induction and chemoradiotherapy in EGFR-mutant stage III non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study. Int J Clin Oncol. 2025;30(3):497-503.
31. Juge M, Imada T, Hirose M, Sato K. Anastrozole-induced interstitial lung disease followed by tamoxifen-induced agranulocytosis in a patient with breast cancer. Int Cancer Conf J. 2025;14(2): 91-96.
32. Takigawa Y, Sato K, Kudo K, Inoue T, Fujiwara M, Matsuoka S, Watanabe H, Sato A, Mukai T, Fujiwara K. Safety and efficacy of airway stent placement following bronchial artery embolization: A retrospective study at a single institute. Respir Investig. 2024;62(4):640-644.
33. Takigawa Y, Sato K, Kudo K, Minami D, Shiraha K, Inoue T, Matsuoka S, Fujiwara M, Mitsumune S, Watanabe H, Sato A, Fujiwara K, Shibayama T. Effectiveness of AERO Stent Placement for Malignant Airway Disorder in Patients with a Poor Performance Status. Intern Med. 2024;63(16):2277-2282.
34. Takigawa Y, Sato K, Kudo K, Minami D, Shiraha K, Inoue T, Matsuoka S, Fujiwara M, Mitsumune S, Watanabe H, Sato A, Fujiwara K, Shibayama T. Effectiveness of AERO Stent Placement for Malignant Airway Disorder in Patients with a Poor Performance Status. Intern Med. 2024;63(16):2277-2282.
35. Takigawa Y, Watanabe H, Sato K, Goda M, Inoue T, Fujiwara M, Matsuoka S, Kudo K, Sato A, Fujiwara K, Shibayama T. Successful ultrathin bronchoscopy with cryobiopsy for diagnosing and removing mucus plugs in allergic bronchopulmonary mycosis mimicking lung cancer. Respirol Case Rep. 2024;12(4):e01359.
36. Takigawa Y, Sato K, Inoue T, Takada M, Fujiwara K. Image of a thawed frozen specimen obtained using a cryoprobe floated with oil droplets in normal saline: An endobronchial lipomatous hamartoma image. Respirol Case Rep. 2024;12(3):e01318.
37. Takigawa Y, Sato K, Inoue T, Sato A, Furutaguchi Y, Goda M, Shiraha K, Fujiwara M, Matsuoka S, Mitsumune S, Watanabe H, Kudo K, Fujiwara K, Shibayama T. Airway stenosis secondary to mediastinal lymph node metastasis of lung adenocarcinoma treated with AERO stent and osimertinib: A case report. Respirol Case Rep. 2024;12(5):e01383.
38. Takigawa Y, Sato K, Kudo K, Ichikawa T, Sasano Y, Matsumoto S, Inoue T, Fujiwara M, Matsuoka S, Watanabe H, Sato A, Fujiwara K, Shibayama T. Successful treatment of tracheal stenosis due to a broken uncovered metallic stent placed over 20 years ago in a patient with recurrent polychondritis using argon plasma coagulation and airway ballooning. Respirol Case Rep. 2024;12(9):e70034.
39. Takigawa Y, Sato K, Inoue T, Takada M, Fujiwara K. Image of a thawed frozen specimen obtained using a cryoprobe floated with oil droplets in normal saline: An endobronchial lipomatous hamartoma image. Respirol Case Rep. 2024;12(3):e01318.
40. Takigawa Y, Watanabe H, Sato K, Matsuoka S, Kudo K, Sato A, Isoda T, Shinno Y, Fujiwara K, Shibayama T. A Case of Lung Metastasis of Breast Cancer Diagnosed Using Ultrathin Bronchoscopic Cryobiopsy with a "Tube-wedging Method". Respir Endosc. 2024;2(1):32-35.
41. Takigawa Y, Miyake K, Sato K, Fujiwara K, Shiraha K, Inoue T, Fujiwara M, Matsuoka S, Watanabe H, Kudo K, Sato A, Watanabe Y, Shibayama T. Improved Bronchial Tree Image Reconstruction from the Lateral Decubitus Position of Computed Tomography Images for Virtual Navigation: A Case Report. Respir Endosc. 2024;2(1):48-52.
42. Matsuoka S, Fujiwara K, Takigawa Y, Ito S, Mitsumune S, Shiraha K, Goda M, Inoue T, Fujiwara M, Nakamura E, Watanabe H, Kudo K, Sato A, Sato K, Shibayama T. Secondary Pulmonary Alveolar Proteinosis Development during the Treatment for Anti-aminoacyl-tRNA Synthetase Antibody-positive Interstitial Lung Disease. Intern Med. 2024;63(21):2971-2976.
43. Matsuoka S, Takigawa Y, Sato K, Sato A, Isoda T. Follicular Lymphoma Diagnosed Successfully via Endobronchial Ultrasound-Guided Intranodal Forceps Biopsy Located in Left Lymph Node #12. Cureus. 2024;16(11):e73486.
44. Matsuoka S, Takigawa Y, Sato K, Inoue T, Watanabe H, Kudo K, Sato A, Fujiwara K, Shibayama T. Convex endobronchial ultrasound bronchoscope may enhance visualization and diagnosis by respiratory physicians: Clinical image of an endoscopic ultrasound with bronchoscope. Respirol Case Rep. 2024;12(11):e70072.
45. Fujiwara M, Watanabe H, Takigawa Y, Goda M, Shiraha K, Inoue T, Matsuoka S, Kudo K, Sato A, Sato K, Fujiwara K, Shibayama T. Successful treatment of type B2 thymoma with steroid and radiotherapy. Respirol Case Rep. 2024;12(8):e70006
46. Shiraha K, Watanabe H, Fujiwara K, Goda M, Inoue T, Fujiwara M, Matsuoka S, Takigawa Y, Mitsumune S, Kudo K, Sato A, Sato K, Shinno Y, Shibayama T. Autopsy case of meningoencephalitis induced by nivolumab and ipilimumab in a patient being treated for non-small cell lung cancer. Intern Med. 2024;63(24):3345-3351.
47. Shiraha K, Takigawa Y, Sato A, Fujiwara K, Matsuo Y, Goda M, Inoue T, Nakamura E, Fujiwara M, Matsuoka S, Watanabe H, Kudo K, Sato K, Shibayama T. Large-vessel vasculitis induced by pegfilgrastim and immune checkpoint inhibitor in a patient with small-cell lung cancer. Respirol Case Rep. 2024;12(2):e01291.
48. Taoka M, Ichihara E, Yokoyama T, Inoue K, Tamura T, Sato A, Oda N, Kano H, Nakamura K, Kawai H, Inoue M, Ochi N, Fujimoto N, Ichikawa H, Ando C, Oze I, Kiura K, Maeda Y, Hotta K. Frequency and Significance of Body Weight Loss During Immunochemotherapy in Patients with Advanced Non-Small Cell Lung Cancer. Cancers (Basel). 2024;16(23):4089.
49. Ichihara E, Ochi N, Makimoto G, Kudo K, Harada D, Ozaki Y, Nishio H, Tsuchihashi K, Miura Y, Endo M, Yano S, Maruyama D, Yoshinami T, Susumu N, Takekuma M, Motohashi T, Ito M, Baba E, Uchino K, Kimura T, Kamiyama Y, Nakao S, Tamura S, Nishimoto H, Kato Y, Sato A, Takano T, Kubo T. Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022. Int J Clin Oncol. 2024;29(4):355-362.
50. Tsuge M, Ichihara E, Hasegawa K, Kudo K, Tanimoto Y, Nouso K, Oda N, Mitsumune S, Kimura G, Yamada H, Takata I, Mitsuhashi T, Taniguchi A, Tsukahara K, Aokage T, Hagiya H, Toyooka S, Tsukahara H, Maeda Y. Increased Oxidative Stress and Decreased Citrulline in Blood Associated with Severe Novel Coronavirus Pneumonia in Adult Patients. Int J Mol Sci. 2024;25(15):8370.
51. Shiiba R, Sano M, Kogure Y, Murao H, Takigawa Y, Torii A, Yamada A, Shinohara Y, Niwa H, Kitagawa C, Oki M. A case of community-acquired Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus (MRSA) necrotizing pneumonia successfully treated with two anti-MRSA drugs. Respir Med Case Rep. 2024;49:102023.
52. Fujiwara S, Higuchi Y, Furujo M, Goda M, Takigawa Y, Sato K, Hitomi K, Mukai W, Oiwa M. Seven-year-old boy with severe dyspnoea and influenza virus infection. J Paediatr Child Health. 2024;60(10):619-620.
53. Morita A, Ichihara E, Inoue K, Fujiwara K, Yokoyama T, Harada D, Ando C, Kano H, Oda N, Tamura T, Ochi N, Kawai H, Inoue M, Hara N, Fujimoto N, Ichikawa H, Oze I, Hotta K, Maeda Y, Kiura K. Impacts of probiotics on the efficacies of immune checkpoint inhibitors with or without chemotherapy for patients with advanced non-small-cell lung cancer. Int J Cancer. 2024;154(9):1607-1615.
54. Kuribayashi T, Ohashi K, Nishii K, Ninomiya K, Tsubata Y, Ishikawa N, Kodani M, Kanaji N, Yamasaki M, Fujitaka K, Kuyama S, Takigawa N, Fujimoto N, Kubota T, Inoue M, Fujiwara K, Harita S, Takata I, Takada K, Okawa S, Kiura K, Hotta K. Clinical characteristics of patients treated with immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: CS-Lung-003 prospective observational registry study. J Cancer Res Clin Oncol. 2024;150(2):89.
55. Oguma T, Ishiguro T, Kamei K, Tanaka J, Suzuki J, Hebisawa A, Obase Y, Mukae H, Tanosaki T, Furusho S, Kurokawa K, Watai K, Matsuse H, Harada N, Nakamura A, Shibayama T, Baba R, Fukunaga K, Matsumoto H, Ohba H, Sakamoto S, Suzuki S, Tanaka S, Yamada T, Yamasaki A, Fukutomi Y, Shiraishi Y, Toyotome T, Fukunaga K, Shimoda T, Konno S, Taniguchi M, Tomomatsu K, Okada N, Asano K, Japan ABPM Research Program. Clinical characteristics of allergic bronchopulmonary mycosis caused by Schizophyllum commune. Clin Transl Allergy. 2024;14(1):e12327.
56. Miyake K, Senoo S, Shiiba R, Itano J, Kimura G, Kawahara T, Tamura T, Kudo K, Kawamura T, Nakahara Y, Higo H, Himeji D, Takigawa N, Miyahara N, Okayama Resp Dis Study Grp ORDSG. Pneumocystis jirovecii pneumonia mortality risk associated with preceding long-term steroid use for the underlying disease: A multicenter, retrospective cohort study. PLoS One. 2024;19(2): e0292507.
57. Takigawa Y, Fujiwara K, Tabuchi I, Kudo K, Hayashi K, Matsumoto S, Omori H, Matsuoka S, Mitsumune S, Watanabe H, Sato A, Sato K, Shibayama T. Successful Treatment with Mepolizumab for Coronary Spastic Angina Associated with Eosinophilic Granulomatosis with Polyangiitis. Intern Med. 2023;62(16):2389-2393.
58. Takigawa Y, Watanabe H, Omote Y, Kurihara S, Inoue T, Fujiwara M, Mitsumune S, Onishi K, Kudo K, Sato A, Sato K, Fujiwara K, Shibayama T. Lambert-Eaton Myasthenic Syndrome Recurrence Induced by Pembrolizumab in a Patient with Non-small-cell Lung Cancer. Intern Med. 2023;62(7):1055-1058.
59. Goda M, Takigawa Y, Fujiwara K, Shinno Y. Upper Lobe-predominant Autoimmune Pulmonary Alveolar Proteinosis. Intern Med. 2023;62(10):1569-1570.
60. Shiraha K, Takigawa Y, Watanabe H, Fujiwara M, Shibayama T. Bronchoscopic Findings of Hereditary Hemorrhagic Telangiectasia. Respir Endosc. 2023;1(2):137-138.
61. Minami D, Takigawa N, Sato K, Fujiwara K, Shibayama T. Distress during Bronchoscopy in Patients Who Underwent Endobronchial Intubation Using Fentanyl and Midazolam without Throat Anesthesia: A Prospective Study. Respir Endosc. 2023;1(1):1-5.
62. Minami D, Onishi K, Hosoya T, Hosoya M, Fujiwara K. Lung Adenocarcinoma with Massive Calcified Lymphadenopathy and Thyroid Metastases. Respir Endosc. 2023;1(1):26-27.
63. Kubo T, Ichihara E, Harada D, Inoue K, Fujiwara K, Hosokawa S, Kishino D, Kawai H, Ochi N, Oda N, Hara N, Hotta K, Tabata M, Maeda Y, Kiura K. Efficacy of immune checkpoint inhibitor monotherapy in elderly patients with non-small-cell lung cancer. Respir Investig. 2023;61(5):643-650.
64. Ando C, Ichihara E, Nishi T, Morita A, Hara N, Takada K, Nakasuka T, Watanabe H, Kano H, Nishii K, Makimoto G, Kondo T, Ninomiya K, Fujii M, Kubo T, Ohashi K, Matsuoka KI, Hotta K, Tabata M, Maeda Y, Kiura K. Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK-rearranged non-small cell lung cancer. Cancer Sci. 2023;114(11):4343-4354.
65. Ichihara E, Hasegawa K, Kudo K, Tanimoto Y, Nouso K, Oda N, Mitsumune S, Yamada H, Takata I, Hagiya H, Mitsuhashi T, Taniguchi A, Toyooka S, Tsukahara K, Aokage T, Tsukahara H, Kiura K, Maeda Y. A randomized controlled trial of teprenone in terms of preventing worsening of COVID-19 infection. PLoS One. 2023;18(10):e0287501.
66. Ninomiya T, Ishikawa N, Kozuki T, Kuyama S, Inoue K, Yokoyama T, Kanaji N, Yasugi M, Shibayama T, Aoe K, Ochi N, Fujitaka K, Kodani M, Ueda Y, Watanabe K, Bessho A, Sugimoto K, Oze I, Hotta K, Kiura K. A randomized phase II study of afatinib alone or combined with bevacizumab for treating chemo-naïve patients with non-small cell lung cancer harboring EGFR mutations. Lung Cancer. 2023;184:107349.
67. Ichihara E, Ochi N, Makimoto G, Kudo K, Harada D, Ozaki Y, Nishio H, Tsuchihashi K, Miura Y, Endo M, Yano S, Maruyama D, Yoshinami T, Susumu N, Takekuma M, Motohashi T, Ito M, Baba E, Uchino K, Kimura T, Kamiyama Y, Nakao S, Tamura S, Nishimoto H, Kato Y, Sato A, Takano T, Kubo T. Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022. Int J Clin Oncol. 2023;29(4):355-362.
68. Ando C, Ichihara E, Yokoyama T, Inoue K, Tamura T, Fujiwara K, Oda N, Kano H, Kishino D, Watanabe K, Inoue M, Ochi N, Onishi F, Ichikawa H, Kobe H, Tachibana S, Hotta K, Maeda Y, Kiura K. More than one-third of advanced non-small-cell lung cancer patients do not receive immunochemotherapy due to intolerance. J Cancer Res Clin Oncol. 2023;149(8):4933-4938.
69. Nakasuka T, Ohashi K, Nishii K, Hirabae A, Okawa S, Tomonobu N, Takada K, Ando C, Watanabe H, Makimoto G, Ninomiya K, Fujii M, Kubo T, Ichihara E, Hotta K, Tabata M, Kumon H, Maeda Y, Kiura K. PD-1 blockade augments CD8+ T cell dependent antitumor immunity triggered by Ad-SGE-REIC in Egfr-mutant lung cancer. Lung Cancer. 2023;178:1-10.
70. Kogure Y, Kada A, Hashimoto H, Atagi S, Takiguchi Y, Saka H, Ebi N, Inoue A, Kurata T, Fujita Y, Nishii Y, Itani H, Endo T, Saito AM, Shibayama T, Yamamoto N, Gemma A. Survival Impact of Second-Line Immune Checkpoint Inhibitors in Older Patients With Advanced Squamous-Cell NSCLC: Post Hoc Analysis of the CAPITAL Study. JTO Clin Res Rep. 2023;4(6):100514.
71. Takigawa Y, Sato K, Inoue A, Nagae M, Inoue T, Onishi K, Mitsumune S, Watanabe H, Kudo K, Sato A, Fujiwara K, Shibayama T. Acute eosinophilic pneumonia caused by nicotine-free vaping in an adolescent patient: A case report. Respirol Case Rep. 2022;10(6):e0961.
72. Tanzawa S, Makiguchi T, Tasaka S, Inaba M, Ochiai R, Nakamura J, Inoue K, Kishikawa T, Nakashima M, Fujiwara K, Kohyama T, Ishida H, Kuyama S, Miyazawa N, Nakamura T, Miyawaki H, Oda N, Ishikawa N, Morinaga R, Kusaka K, Miyamoto Y, Yokoyama T, Matsumoto C, Tsuda T, Ushijima S, Shibata K, Shibayama T, Bessho A, Kaira K, Misumi T, Shiraishi K, Matsutani N, Seki N. Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study). Ther Adv Med Oncol. 2022;14:17588359221116603.
73. Nishimura T, Ichihara E, Yokoyama T, Inoue K, Tamura T, Sato K, Oda N, Kano H, Kishino D, Kawai H, Inoue M, Ochi N, Fujimoto N, Ichikawa H, Ando C, Hotta K, Maeda Y, Kiura K. The Effect of Pleural Effusion on Prognosis in Patients with Non-Small Cell Lung Cancer Undergoing Immunochemotherapy: A Retrospective Observational Study. Cancers (Basel). 2022;14(24):6184.
74. Nishii K, Ohashi K, Tomida S, Nakasuka T, Hirabae A, Okawa S, Nishimura J, Higo H, Watanabe H, Kano H, Ando C, Makimoto G, Ninomiya K, Kato Y, Kubo T, Ichihara E, Hotta K, Tabata M, Toyooka S, Udono H, Maeda Y, Kiura K. CD8+ T-cell Responses Are Boosted by Dual PD-1/VEGFR2 Blockade after EGFR Inhibition in Egfr-Mutant Lung Cancer. Cancer Immunol Res. 2022;10(9):1111-1126.
75. Noumi T, Watanabe H, Ninomiya K, Ohashi K, Ichihara E, Kubo T, Makimoto G, Kato Y, Fujii M, Tabata M, Maeda Y, Hotta K, Kiura K. COVID-19 Vaccine-Associated Lymphadenopathy Mimicking Regrowth of Axillary Lymph Node Metastasis of Lung Adenocarcinoma. Acta Med Okayama. 2022;76(5):593-596.
76. Terai H, Soejima K, Shimokawa A, Horinouchi H, Shimizu J, Hase T, Kanemaru R, Watanabe K, Ninomiya K, Aragane N, Yanagitani N, Sakata Y, Seike M, Fujimoto D, Kasajima M, Kubo A, Kusumoto S, Oyamada Y, Fujiwara K, Mori M, Hashimoto M, Shingyoji M, Kodani M, Sakamoto J, Agatsuma T, Kashiwabara K, Inomata M, Tachihara M, Tanaka K, Hayashihara K, Koyama N, Matsui K, Minato K, Jingu D, Sakashita H, Hara S, Naito T, Okada A, Tanahashi M, Sato Y, Asano K, Takeda T, Nakazawa K, Harada T, Shibata K, Kato T, Miyaoka E, Yoshino I, Gemma A, Mitsudomi T. Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance Data. JTO Clin Res Rep. 2022;3(11):100404.
77. Tanaka H, Tanzawa S, Misumi T, Makiguchi T, Inaba M, Honda T, Nakamura J, Inoue K, Kishikawa T, Nakashima M, Fujiwara K, Kohyama T, Ishida H, Kuyama S, Miyazawa N, Nakamura T, Miyawaki H, Oda N, Ishikawa N, Morinaga R, Kusaka K, Fujimoto N, Fukuda Y, Yasugi M, Tsuda T, Ushijima S, Shibata K, Shibayama T, Bessho A, Kaira K, Shiraishi K, Matsutani N, Seki N. A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis. Ther Adv Med Oncol. 2022;14:17588359221142786.
78. Matsuura H, Fujiwara K, Omori H, Onishi K, Kuribayashi T, Mitsumune S, Takigawa Y, Kudo K, Minami D, Sato A, Sato K, Shibayama T. Successful Treatment with Benralizumab for Allergic Bronchopulmonary Aspergillosis that Developed after Disastrous Heavy Rainfall in Western Japan. Intern Med. 2021;60(9):1443-1450.
79. Matsuura H, Fujiwara K, Omori H, Onishi K, Kuribayashi T, Mitsumune S, Takigawa Y, Kudo K, Sato A, Sato K, Shibayama T. Reply to "Benralizumab as First-line Treatment for ABPA: Is It Really Indicated?". Intern Med. 2021;60(15):2521.
80. Takada K, Fujiwara K, Ando E, Onishi K, Kuribayashi T, Mitsumune S, Takigawa Y, Matsuura H, Watanabe H, Kudo K, Sato A, Sato K, Shibayama T. Optic Perineuritis Associated with Nivolumab Treatment for Non-Small Cell Lung Cancer. Case Rep Oncol. 2021;14(2):792-796.
81. Kuribayashi T, Fujiwara K, Onishi K, Mitsumune S, Takigawa Y, Watanabe H, Kudo K, Sato A, Sato K, Kitagawa M, Ota K, Shinno Y, Shibayama T. Thrombotic Microangiopathy Associated with Gemcitabine in Non-Small Cell Lung Cancer: A Case Report. Case Rep Oncol. 2021;14(3):1712-1718.
82. Minami D, Murakami E, Shibata Y, Nakamura K, Kishino T, Takigawa N, Onishi K, Takigawa Y, Shimonishi A, Kudo K, Sato A, Sato K, Fujiwara K, Shibayama T. End-tidal capnographic monitoring during flexible bronchoscopy under fentanyl and midazolam sedation. Ann Palliat Med. 2021;10(8):8665-8671.
83. Ninomiya K, Yokoyama T, Hotta K, Oze I, Katsui K, Hata T, Yoshioka H, Bessho A, Hosokawa S, Kuyama S, Kudo K, Kozuki T, Harada D, Yasugi M, Murakami T, Nakanishi M, Takigawa N, Maeda Y, Kiura K; Okayama Lung Cancer Study Group. A randomized trial of sodium alginate prevention of esophagitis in LA-NSCLC receiving chemoradiotherapy: OLCSG1401. Support Care Cancer. 2021;29(9):5237-5244.
84. Ninomiya T, Nogami N, Kozuki T, Harada D, Kubo T, Ohashi K, Ichihara E, Kuyama S, Kudo K, Bessho A, Sakugawa M, Fujimoto N, Aoe K, Minami D, Sugimoto K, Ochi N, Takigawa N, Hotta K, Maeda Y, Kiura K.. Survival of chemo-naïve patients with EGFR mutation-positive advanced non-small cell lung cancer after treatment with afatinib and bevacizumab: updates from the Okayama Lung Cancer Study Group Trial 1404. Jpn J Clin Oncol. 2021;51(8):1269-1276.
85. Tamura T, Ninomiya K, Kubo T, Kuyama S, Tachibana S, Inoue K, Chikamori K, Kudo K, Ochi N, Harada D, Maeda Y, Kiura K. Short-term safety of an anti-severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine for patients with advanced lung cancer treated with anticancer drugs: A multicenter, prospective, observational study. Thorac Cancer. 2021;13(3):453-459.
86. Watanabe H, Ichihara E, Kayatani H, Makimoto G, Ninomiya K, Nishii K, Higo H, Ando C, Okawa S, Nakasuka T, Kano H, Hara N, Hirabae A, Kato Y, Ninomiya T, Kubo T, Rai K, Ohashi K, Hotta K, Tabata M, Maeda Y, Kiura K. VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene-driven non-small-cell lung cancers. Cancer Sci. 2021;112(5):1853-1864.
87. Nishii K, Ohashi K, Watanabe H, Makimoto G, Nakasuka T, Higo H, Ninomiya K, Kato Y, Kubo T, Rai K, Ichihara E, Hotta K, Tabata M, Maeda Y, Kiura K. Triple therapy with osimertinib, bevacizumab and cetuximab in EGFR-mutant lung cancer with HIF-1α/TGF-α expression. Oncol Lett. 2021;22(3):639.
88. Kano H, Ichihara E, Watanabe H, Nishii K, Ando C, Nakasuka T, Ninomiya K, Kato Y, Kubo T, Rai K, Ohashi K, Hotta K, Tabata M, Maeda Y, Kiura K. SHP2 Inhibition Enhances the Effects of Tyrosine Kinase Inhibitors in Preclinical Models of Treatment-naïve ALK-, ROS1-, or EGFR-altered Non-small Cell Lung Cancer. Mol Cancer Ther. 2021;20(9):1653-1662.
89. Nakasuka T, Ohashi K, Watanabe H, Kubo T, Matsumoto S, Goto K, Hotta K, Maeda Y, Kiura K. A case of dramatic reduction in cancer-associated thrombus following initiation of pembrolizumab in patient with a poor performance status and PD-L1 + lung adenocarcinoma harboring CCDC6-RET fusion gene and NF1/TP53 mutations. Lung Cancer. 2021;156:1-4.
90. Hara N, Ichihara E, Harada D, Inoue K, Fujiwara K, Hosokawa S, Kishino D, Kawai H, Ochi N, Oda N, Hotta K, Maeda Y, Kiura K. Significance of PD-L1 expression in the cytological samples of non-small cell lung cancer patients treated with immune checkpoint inhibitors. J Cancer Res Clin Oncol. 2021;147(12):3749-3755.
91. Nishii K, Inoue M, Obata H, Ueda Y, Kozuki T, Yamasaki M, Moritaka T, Awaya Y, Sugimoto K, Gemba K, Kuyama S, Ichikawa H, Shibayama T, Kubota T, Kodani M, Kishino D, Fujimoto N, Ishikawa N, Tsubata Y, Ishii T, Fujitaka K, Hotta K, Kiura K. Novel prospective umbrella-type lung cancer registry study for clarifying clinical practice patterns: CS-Lung-003 study protocol. Thorac Cancer. 2021;12(5):725-731.
92. Ochi N, Ichihara E, Takigawa N, Harada D, Inoue K, Shibayama T, Hosokawa S, Kishino D, Harita S, Oda N, Hara N, Hotta K, Maeda Y, Kiura K. The effects of antibiotics on the efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancer differ based on PD-L1 expression. Eur J Cancer. 2021;149:73-81.
93. Ochi N, Ichihara E, Takigawa N, Harada D, Inoue K, Shibayama T, Hosokawa S, Kishino D, Harita S, Oda N, Hara N, Hotta K, Maeda Y, Kiura K. Response to letter re: The effects of antibiotics on the efficacy of immune-checkpoint inhibitors in non-small cell lung cancer patients differ according to PD-L1 expression. Eur J Cancer. 2021;157:523-524.
94. Ichihara E, Harada D, Inoue K, Shibayama T, Hosokawa S, Kishino D, Harita S, Ochi N, Oda N, Hara N, Hotta K, Maeda Y, Kiura K. Characteristics of patients with EGFR-mutant non-small-cell lung cancer who benefited from immune checkpoint inhibitors. Cancer Immunol Immunother. 2021;70(1):101-106.
95. Hosokawa S, Ichihara E, Bessho A, Harada D, Inoue K, Shibayama T, Kishino D, Harita S, Ochi N, Oda N, Hara N, Hotta K, Maeda Y, Kiura K. Impact of previous thoracsic radiation therapy on the efficacy of immune checkpoint inhibitors in advanced non-smasll-cell lung cancer. Jpn J Clin Oncol. 2021;51(2):279-286.
96. Tanzawa S, Ushijima S, Shibata K, Shibayama T, Bessho A, Kaira K, Misumi T, Shiraishi K, Matsutani N, Tanaka H, Inaba M, Haruyama T, Nakamura J, Kishikawa T, Nakashima M, Iwasa K, Fujiwara K, Kohyama T, Kuyama S, Miyazawa N, Nakamura T, Miyawaki H, Ishida H, Oda N, Ishikawa N, Morinaga R, Kusaka K, Fujimoto N, Yokoyama T, Gemba K, Tsuda T, Nakagawa H, Ono H, Shimizu T, Nakamura M, Kusumoto S, Hayashi R, Shirasaki H, Ochi N, Aoe K, Kanaji N, Kashiwabara K, Inoue H, Seki N. A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study). Ther Adv Med Oncol. 2021;13:1758835921998588.
和文論文
1. 市川健, 瀧川雄貴, 佐藤賢, 白羽慶祐, 井上智敬, 松本奨一朗, 向井敬, 江田良輔, 藤原慶一, 柴山卓夫。大量喀血後の気道閉塞に対して気管支動脈塞栓術後のCryotherapyが有効であった1例。気管支学2026:48(1):87-92.
2. 瀧川雄貴、佐藤賢、荒木佑亮、井上智敬、市川健、渡邉洋美、工藤健一郎、佐藤晃子、藤原慶一、柴山 卓夫。気管扁平上皮癌による声門下の気道狭窄に対してラリンゲルマスク下でクライオセラピーを行った1例。気管支学2025:47(2):155-160.
3. 藤原美穂、佐藤賢、瀧川雄貴、郷田真由、井上智敬、松岡涼果、渡邉洋美、工藤健一郎、藤原慶一、 柴山卓夫。成人における鋭的気道異物の2例。気管支学2025:47(2):114-119.
4. 松本奨一朗、瀧川雄貴、佐藤賢、市川健、光宗翔、渡邉洋美、工藤健一郎、佐藤晃子、藤原慶一、柴山卓夫。Endobronchial Watanabe Spigot（EWS）にて止血しえた経気管支肺生検後の出血の1例。気管支学2025:47(5)460-464.
5. 井戸聡子、瀧川雄貴、佐藤賢、工藤健一郎、井上智敬、松岡涼果、渡邉洋美、佐藤晃子、藤原慶一、柴山卓夫。食道癌に伴う気道狭窄、食道気管瘻、食道縦隔瘻に対するダブルステント留置を行った3症例。気管支学2025:47(5):471-477.
6. 伊藤沙妃、藤原美穂、工藤健一郎、光宗翔、岩本佳隆、藤原慶一。肺腺癌術後17年目で再発したと考えられた髄膜癌腫症の1例。日呼吸誌, 14(1): 24-28, 2025.
7. 來間俊介、白羽慶祐、瀧川雄貴、佐藤晃子、郷田真由、渡邉洋美、工藤健一郎、佐藤賢、藤原慶一、柴山卓夫。過敏性肺炎パターンを呈したメサラジンによる薬剤性肺炎をクライオ生検で診断した1例。気管支学2025:47(3)219-224.
8. 藤原慶一。緩和医療：終末期医療。日本臨床腫瘍学会（編） 新臨床腫瘍学, 南江堂 2024年, pp.715-718。
9. 瀧川雄貴、佐藤賢、井上智敬、藤原美穂、松岡涼果、渡邉洋美、工藤健一郎、佐藤晃子、藤原慶一、柴山卓夫。院内標準化を目指したEndoscopic ultrasound with bronchoscope-guided fine-needle aspiration: EUS-B-FNAの後方視的検討。気管支学2024;46(6):404-409.
10. 藤原美穂、渡邉洋美、郷田真由、藤原慶一、太田康介、柴山卓夫。抗MDA5抗体、抗ARS抗体がともに陽性であった皮膚筋炎関連間質性肺炎の１例。日呼吸誌 13(4): 148-154, 2024.
11. 松岡涼果、藤原慶一、市川健、大森洋樹、中村愛理、藤原美穂。慢性気道感染症と鑑別を要し、クライオ肺生検で診断したIgG4関連呼吸器疾患の1例。日呼吸誌2023;12(3):114-118.
12. 山原美穂、藤原慶一、栗林忠弘、松岡涼果、牧田雅典、柴山卓夫。珪肺に合併し、閉塞性肺炎と前縦隔腫瘤を契機に診断された形質芽球性リンパ腫の1例。日呼吸誌2022;11(2):103-108.
13. 白羽慶祐、工藤健一郎、藤原慶一、光宗翔、吉田秀行、柴山卓夫。脳室腹腔短絡術によりオシメルチニブ内服が可能となった肺癌髄膜癌腫症の1例。日呼吸誌2023;12(2):93-97.
14. 白羽慶祐, 瀧川雄貴, 佐藤賢, 山下真弘, 井上智敬, 中村愛理, 藤原美穂, 藤原慶一, 神農陽子, 柴山卓夫。多形腺腫摘出10年後に認められた肺転移に対してEUS-B-FNAで診断した1例。気管支学2023;45(6): 425-430.
15. 瀧川雄貴、佐藤賢、光宗翔、岩本佳隆、工藤健一郎、藤原慶一。高周波スネアを用いて気管支鏡下に切除した気管支過誤腫の8例。日呼吸誌2022;11(2):113-116.
16. 瀧川雄貴、渡邉洋美、佐藤賢、永喜多敬奈、神農陽子、藤原慶一。超音波気管支鏡ガイド下針生検にて診断した胸腺上皮性腫瘍の2例。日呼吸誌2022;11(4):178-182.
17. 瀧川雄貴、佐藤賢、工藤健一郎、松本奨一朗、栗林忠弘、大西桐子、光宗翔、渡邉洋美、佐藤晃子、藤原慶一。軟性気管支鏡下に高周波スネアにて切除しえた術後気管支内転移した胸腺腫の1例。気管支学2022;44(2):171-176.
18. 瀧川雄貴、工藤健一郎、佐藤賢、井上智敬、大西桐子、光宗翔、渡邉洋美、佐藤晃子、藤原慶一、柴山卓夫。繰り返すEWS気管支充填術にて外科治療を回避し、有瘻性膿胸の治療に成功した1例。気管支学2022;44(4):300-304.
19. 津野夏美、瀧川雄貴、佐藤賢、光宗翔、渡邉洋美、工藤健一郎、佐藤晃子、藤原慶一、岩本康男、柴山卓夫。大腸癌縦隔リンパ節転移気管浸潤による気道狭窄に対し気道インターベンションを施行し、呼吸機能が改善した1例。気管支学2022;44(6):432-436.
20. 藤原慶一。緩和医療：終末期医療。日本臨床腫瘍学会（編）南江堂 2021年。新臨床腫瘍学 pp.361-364.
21. 瀧川雄貴、佐藤賢、栗林忠弘、大西桐子、光宗翔、松浦宏昌、渡邉洋美、工藤健一郎、藤原慶一。硬性気管支鏡下に切除した縫合糸による気管支異物肉芽腫の1例。気管支学2021;43(5):468-472.
2. 瀧川雄貴、佐藤賢、荒木佑亮、井上智敬、市川健、渡邉洋美、工藤健一郎、佐藤晃子、藤原慶一、柴山 卓夫。気管扁平上皮癌による声門下の気道狭窄に対してラリンゲルマスク下でクライオセラピーを行った1例。気管支学2025:47(2):155-160.
3. 藤原美穂、佐藤賢、瀧川雄貴、郷田真由、井上智敬、松岡涼果、渡邉洋美、工藤健一郎、藤原慶一、 柴山卓夫。成人における鋭的気道異物の2例。気管支学2025:47(2):114-119.
4. 松本奨一朗、瀧川雄貴、佐藤賢、市川健、光宗翔、渡邉洋美、工藤健一郎、佐藤晃子、藤原慶一、柴山卓夫。Endobronchial Watanabe Spigot（EWS）にて止血しえた経気管支肺生検後の出血の1例。気管支学2025:47(5)460-464.
5. 井戸聡子、瀧川雄貴、佐藤賢、工藤健一郎、井上智敬、松岡涼果、渡邉洋美、佐藤晃子、藤原慶一、柴山卓夫。食道癌に伴う気道狭窄、食道気管瘻、食道縦隔瘻に対するダブルステント留置を行った3症例。気管支学2025:47(5):471-477.
6. 伊藤沙妃、藤原美穂、工藤健一郎、光宗翔、岩本佳隆、藤原慶一。肺腺癌術後17年目で再発したと考えられた髄膜癌腫症の1例。日呼吸誌, 14(1): 24-28, 2025.
7. 來間俊介、白羽慶祐、瀧川雄貴、佐藤晃子、郷田真由、渡邉洋美、工藤健一郎、佐藤賢、藤原慶一、柴山卓夫。過敏性肺炎パターンを呈したメサラジンによる薬剤性肺炎をクライオ生検で診断した1例。気管支学2025:47(3)219-224.
8. 藤原慶一。緩和医療：終末期医療。日本臨床腫瘍学会（編） 新臨床腫瘍学, 南江堂 2024年, pp.715-718。
9. 瀧川雄貴、佐藤賢、井上智敬、藤原美穂、松岡涼果、渡邉洋美、工藤健一郎、佐藤晃子、藤原慶一、柴山卓夫。院内標準化を目指したEndoscopic ultrasound with bronchoscope-guided fine-needle aspiration: EUS-B-FNAの後方視的検討。気管支学2024;46(6):404-409.
10. 藤原美穂、渡邉洋美、郷田真由、藤原慶一、太田康介、柴山卓夫。抗MDA5抗体、抗ARS抗体がともに陽性であった皮膚筋炎関連間質性肺炎の１例。日呼吸誌 13(4): 148-154, 2024.
11. 松岡涼果、藤原慶一、市川健、大森洋樹、中村愛理、藤原美穂。慢性気道感染症と鑑別を要し、クライオ肺生検で診断したIgG4関連呼吸器疾患の1例。日呼吸誌2023;12(3):114-118.
12. 山原美穂、藤原慶一、栗林忠弘、松岡涼果、牧田雅典、柴山卓夫。珪肺に合併し、閉塞性肺炎と前縦隔腫瘤を契機に診断された形質芽球性リンパ腫の1例。日呼吸誌2022;11(2):103-108.
13. 白羽慶祐、工藤健一郎、藤原慶一、光宗翔、吉田秀行、柴山卓夫。脳室腹腔短絡術によりオシメルチニブ内服が可能となった肺癌髄膜癌腫症の1例。日呼吸誌2023;12(2):93-97.
14. 白羽慶祐, 瀧川雄貴, 佐藤賢, 山下真弘, 井上智敬, 中村愛理, 藤原美穂, 藤原慶一, 神農陽子, 柴山卓夫。多形腺腫摘出10年後に認められた肺転移に対してEUS-B-FNAで診断した1例。気管支学2023;45(6): 425-430.
15. 瀧川雄貴、佐藤賢、光宗翔、岩本佳隆、工藤健一郎、藤原慶一。高周波スネアを用いて気管支鏡下に切除した気管支過誤腫の8例。日呼吸誌2022;11(2):113-116.
16. 瀧川雄貴、渡邉洋美、佐藤賢、永喜多敬奈、神農陽子、藤原慶一。超音波気管支鏡ガイド下針生検にて診断した胸腺上皮性腫瘍の2例。日呼吸誌2022;11(4):178-182.
17. 瀧川雄貴、佐藤賢、工藤健一郎、松本奨一朗、栗林忠弘、大西桐子、光宗翔、渡邉洋美、佐藤晃子、藤原慶一。軟性気管支鏡下に高周波スネアにて切除しえた術後気管支内転移した胸腺腫の1例。気管支学2022;44(2):171-176.
18. 瀧川雄貴、工藤健一郎、佐藤賢、井上智敬、大西桐子、光宗翔、渡邉洋美、佐藤晃子、藤原慶一、柴山卓夫。繰り返すEWS気管支充填術にて外科治療を回避し、有瘻性膿胸の治療に成功した1例。気管支学2022;44(4):300-304.
19. 津野夏美、瀧川雄貴、佐藤賢、光宗翔、渡邉洋美、工藤健一郎、佐藤晃子、藤原慶一、岩本康男、柴山卓夫。大腸癌縦隔リンパ節転移気管浸潤による気道狭窄に対し気道インターベンションを施行し、呼吸機能が改善した1例。気管支学2022;44(6):432-436.
20. 藤原慶一。緩和医療：終末期医療。日本臨床腫瘍学会（編）南江堂 2021年。新臨床腫瘍学 pp.361-364.
21. 瀧川雄貴、佐藤賢、栗林忠弘、大西桐子、光宗翔、松浦宏昌、渡邉洋美、工藤健一郎、藤原慶一。硬性気管支鏡下に切除した縫合糸による気管支異物肉芽腫の1例。気管支学2021;43(5):468-472.
・特集診療科紹介 呼吸器内科（ザ ジャーナルVoll.15 No.1より抜粋） (PDF形式)